The estimated Net Worth of Marshall S Geller is at least $11.7 Milion dollars as of 4 December 2023. Mr. Geller owns over 1,100 units of GP Strategies stock worth over $9,139,472 and over the last 20 years he sold GPX stock worth over $2,445,237. In addition, he makes $147,397 as Independent Director at GP Strategies.
Sign up
Mr. Geller GPX stock SEC Form 4 insiders trading
Marshall has made over 54 trades of the GP Strategies stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 1,100 units of GPX stock worth $1,144 on 4 December 2023.
The largest trade he's ever made was exercising 39,308 units of GP Strategies stock on 30 December 2022 worth over $819,572. On average, Marshall trades about 2,088 units every 29 days since 2005. As of 4 December 2023 he still owns at least 438,344 units of GP Strategies stock.
You can see the complete history of Mr. Geller stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Marshall Geller biography
Marshall S. Geller serves as Independent Director of the Company. Mr. has spent more than 50 years in corporate finance and investment banking, including 21 years as a Senior Managing Partner of Bear, Stearns & Co., with oversight of all operations in Los Angeles, San Francisco, Chicago, Hong Kong and the Far East. Mr. Geller is currently on the Board of Directors of UCLA Health System and VerifyMe, Inc. and is on the Board of Governors of Cedars Sinai Medical Center, Los Angeles. Mr. Geller also serves on the Dean's Advisory Council for the College of Business & Economics at California State University, Los Angeles. Previously Mr. Geller was a director of Guidance Software, Inc., National Holdings Corporation, California Pizza Kitchen and Wright Investors' Services Holdings, Inc. Mr. Geller has served on our Board of Directors since 2002. As the managing partner of a private equity fund and a director of other public companies, Mr. Geller brings to the Board many years of experience and expertise as an investor in and adviser to companies in various sectors.
What is the salary of Marshall Geller?
As the Independent Director of GP Strategies, the total compensation of Marshall Geller at GP Strategies is $147,397. There are 7 executives at GP Strategies getting paid more, with Scott Greenberg having the highest compensation of $1,017,500.
How old is Marshall Geller?
Marshall Geller is 81, he's been the Independent Director of GP Strategies since 2002. There are no older and 12 younger executives at GP Strategies.
What's Marshall Geller's mailing address?
Marshall's mailing address filed with the SEC is C/O VERIFYME, INC., 801 INTERNATIONAL PARKWAY, FIFTH FLOOR, LAKE MARY, FL, 32746.
Insiders trading at GP Strategies
Over the last 20 years, insiders at GP Strategies have traded over $11,920,586 worth of GP Strategies stock and bought 1,753,458 units worth $28,771,599 . The most active insiders traders include Capital Partners, L.P.Sagar..., Capital Partners, L.P.Sagar... oraz Daniel M. Friedberg. On average, GP Strategies executives and independent directors trade stock every 10 days with the average trade being worth of $221,823. The most recent stock trade was executed by Russell L. Becker on 26 March 2020, trading 5,000 units of GPX stock currently worth $33,500.
What does GP Strategies do?
GP Strategies Corporation is a global workforce transformation solutions provider of training, digital learning solutions, management consulting and engineering services. GP Strategies' solutions improve the effectiveness of organizations by delivering innovative and superior training, consulting and business improvement services, customized to meet the specific needs of its clients. Clients include Fortune 500 companies, automotive, financial services, technology, and other commercial and government customers.
What does GP Strategies's logo look like?
Complete history of Mr. Geller stock trades at National, GP Strategies oraz VerifyMe
GP Strategies executives and stock owners
GP Strategies executives and other stock owners filed with the SEC include:
-
Scott Greenberg,
Chairman of the Board -
Adam Stedham,
President, Chief Executive Officer, Director -
Donald Duquette,
Executive Vice President -
Russell Becker,
Executive Vice President and Chief Sales Officer -
Michael Dugan,
Chief Financial Officer, Executive Vice President -
Jacques Manardo,
Director -
Samuel Robinson,
Lead Independent Director -
Marshall Geller,
Independent Director -
Richard Pfenniger,
Independent Director -
Steven Koonin,
Independent Director -
Tamar Elkeles,
Independent Director -
James Galante,
Executive Vice President, General Counsel, Secretary -
Patricia Begley,
Executive Vice President -
Matt Donovan,
Chief Learning & Innovation Officer and Sr. VP -
Russell L. Becker,
Chief Growth Officer -
Tony Mok,
Sr. VP of APAC Region -
John M. Ruyter,
Sr. VP of HR -
Jamie Coffey,
Director of Corp. Marketing & Communications -
Ann M. Blank,
Director of Financial Reporting & Investor Relations -
A Marvin Strait,
Director -
Capital Partners, L.P.Sagar...,
-
Karl Baer,
Executive Vice President -
Laura L Gurski,
Director -
Harvey P Eisen,
Director -
Sharon Esposito Mayer,
EVP & Chief Financail Officer -
David A Gugala,
Senior Vice President -
Douglas E Sharp,
-
Miriam H. Strouse,
Director -
Capital Partners, L.P.Sagar...,
-
Deborah Ung,
Senior Vice President -
Daniel M. Friedberg,
Director -
Kenneth L Crawford,
EVP & General Counsel -
Sue W. Kelly,
Director -
Joseph R. Nasal,
Senior Vice President -
James Moran,
Senior Vice President -
Gene Washington,
Director -
Capital Partners Management...,
-
Frederic H. Strickland,
Senior Vice President -
Matthew Zell,
Director -
Alan P Tattersall,
Senior Vice President -
Scott R Peppet,
Director -
Andrea D Kantor,
Director -
Larry T Davis,
Executive Vice President -
Harvey Pbedford Oak Advisor...,
-
Jerome I Feldman,
Director -
Ogden R Reid,
Director -
Klaus Woeste,
Senior Vice President -
William J. Maggio,
Executive Vice President